Edition:
United Kingdom

Akcea Therapeutics Inc (AKCA.OQ)

AKCA.OQ on NASDAQ Stock Exchange Global Select Market

24.39USD
17 Jun 2019
Change (% chg)

$1.65 (+7.26%)
Prev Close
$22.74
Open
$23.05
Day's High
$24.73
Day's Low
$22.98
Volume
94,609
Avg. Vol
81,396
52-wk High
$40.60
52-wk Low
$19.70

Select another date:

Fri, Mar 1 2019

EU committee approves Akcea-Ionis drug for rare genetic disease

March 1 An advisory committee of the European Medicines Agency (EMA) on Friday recommended conditionally approving a drug from Akcea Therapeutics Inc and Ionis Pharmaceuticals Inc that aims to treat a rare genetic disease that causes fat accumulation in the blood.

BRIEF-Akcea Therapeutics Says Co Will Receive A $150 Mln License Fee That Will Be Split Equally With Ionis

* AKCEA-APO(A)-LRX ADVANCES AS LEADING PHARMACEUTICAL COMPANY EXERCISES OPTION TO LICENSE

Select another date: